Figure 1.
Enrollment, randomization, and follow up.
Out of 162 patients who were eligible to the study, 73 patients were enrolled in the study, and 60 patients completed the study for analysis.
Table 1.
Baseline characteristics.
Figure 2.
Survival curve of the Futhan group and No-anticoagulation group.
Table 2.
Comparison of mortality in each group.
Table 3.
Distribution of filter life spans in each group.
Table 4.
Comparison of filters consumed in each group.
Table 5.
Comparison of transfusion in each group.